Agenus expands executive leadership team

Lexington, mass.--(business wire)--immuno-oncology leader, agenus inc. (“agenus”) (nasdaq: agen), today announced the appointment of robin taylor, ph.d., homa yeganegi and stephanie fagan to its executive team. the newly appointed leaders bring a wealth of industry experience to drive the company's next phase of growth in the development and planned commercialization of botensilimab and a deep pipeline of immuno-oncology programs, which offer potential breakthroughs in cancer therapeutics. chie.
AGEN Ratings Summary
AGEN Quant Ranking